Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound - Mydecine Innovations Gr (OTC:MYCOF)
VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a forefront biotechnology company dedicated to